Back to All NewsScreening for Body Dysmorphic Disorder
Posted By American Med Spa Association, Tuesday, January 4, 2022
Share
A study published in the Journal of Cosmetic Dermatology aimed to verify the probability of body dysmorphic disorder (BDD) in cosmetic dermatology.
BDD is defined as an obsession with a perceived defect in physical appearance that is not observable or appears slight to others. This perceived defect typically impairs a patient’s life.
BDD is one of the most common psychiatric conditions for which aesthetic patients receive diagnoses. BDD involves a distorted perception of body image; consequently, aesthetic treatments and procedures can never fulfill patients’ desired but unobtainable result.
The study used a multiphasic screening protocol for BDD that was distributed to 8 medical spa clinics in the United States. The prescreening form was administered to incoming patients aged 18 to 65 years from June 1, 2019, through September 1, 2019. The patients were not made aware that they were being studied in an
attempt to avoid the low sensitivity and specificity that can occur during psychological screenings where patients are highly motivated to succeed in order to be treated. Medical exclusions included any procedure limitation like pregnancy or breastfeeding, allergies to the injected materials, or neuromuscular disorders. There were no exclusions based on psychological reasons.
The multiphasic portion of the study started with an informal, anonymous survey that included questions deemed useful in determining the psychological motivators for treatment.
Read more at Dermatology Times >>
BDD is defined as an obsession with a perceived defect in physical appearance that is not observable or appears slight to others. This perceived defect typically impairs a patient’s life.
BDD is one of the most common psychiatric conditions for which aesthetic patients receive diagnoses. BDD involves a distorted perception of body image; consequently, aesthetic treatments and procedures can never fulfill patients’ desired but unobtainable result.
The study used a multiphasic screening protocol for BDD that was distributed to 8 medical spa clinics in the United States. The prescreening form was administered to incoming patients aged 18 to 65 years from June 1, 2019, through September 1, 2019. The patients were not made aware that they were being studied in an
attempt to avoid the low sensitivity and specificity that can occur during psychological screenings where patients are highly motivated to succeed in order to be treated. Medical exclusions included any procedure limitation like pregnancy or breastfeeding, allergies to the injected materials, or neuromuscular disorders. There were no exclusions based on psychological reasons.
The multiphasic portion of the study started with an informal, anonymous survey that included questions deemed useful in determining the psychological motivators for treatment.
Read more at Dermatology Times >>
